Alogliptin Impurity 11
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1618644-32-8Alogliptin Impurity 11

● In Stock

Catalogue No.:VL5900005
CAS No.:1618644-32-8
Mol. Formula:C25H25N5O3
Mol. Weight:443.51 g/mol

Additional information on CAS 1618644-32-8

Parent drug

Alogliptin

IUPAC Name

(R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2, 6-dioxo-1, 2, 3, 6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide

Synonyms

N/A

Description

Alogliptin Impurity 11 (CAS No: 1618644-32-8) or (R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide, Alogliptin Impurity 11 is an impurity of Alogliptin, it is lower blood glucose by preventing the breakdown of GLP-1 by inhibiting DPP-4.

References

Kaku, Kohei, et al. “Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.” Drug Safety, vol. 42, no. 11, 25 Oct. 2019, pp. 1311–1327, 10.1007/s40264-019-00857-8. Accessed 1 May 2020.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url